Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review

  • ID: 4239705
  • SWOT Analysis
  • 58 pages
  • GlobalData
  • Quest Diagnostics, Inc.
1 of 5

FEATURED COMPANIES

  • Alere Inc
  • Bio-Rad Laboratories Inc
  • Life Technologies Corp
  • Novant Health Inc
  • MORE
Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology and diagnostic products. The company caters to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc Key Recent Developments

Feb 01, 2018: Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter
Jan 30, 2018: ChartMaxx from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’
Jan 23, 2018: Quest Diagnostics to Acquire MedXM, Expanding its Health Risk Assessment Services to Close Gaps in Care
Dec 11, 2017: Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Alere Inc
  • Bio-Rad Laboratories Inc
  • Life Technologies Corp
  • Novant Health Inc
  • MORE
Section 1 - About the Company
  • Quest Diagnostics Inc - Key Facts
  • Quest Diagnostics Inc - Key Employees
  • Quest Diagnostics Inc - Key Employee Biographies
  • Quest Diagnostics Inc - Major Products and Services
  • Quest Diagnostics Inc - History
  • Quest Diagnostics Inc - Company Statement
  • Quest Diagnostics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 – Company Analysis
  • Company Overview
  • Quest Diagnostics Inc - Business Description
  • Business Segment: DIS Segment
  • Overview
  • Performance
  • Key Stats
  • Business Segment: DS Segment
  • Overview
  • Performance
  • Key Stats
  • Quest Diagnostics Inc - Corporate Strategy
  • Quest Diagnostics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Quest Diagnostics Inc - Strengths
  • Quest Diagnostics Inc - Weaknesses
  • Quest Diagnostics Inc - Opportunities
  • Quest Diagnostics Inc - Threats
  • Quest Diagnostics Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Quest Diagnostics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Quest Diagnostics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Feb 01, 2018: Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter
  • Jan 30, 2018: ChartMaxx from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’
  • Jan 18, 2018: Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
  • Dec 19, 2017: Clinical Genomics Pathology Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab
  • Dec 12, 2017: Roy Davis Joins Liquid Biopsy Company Clinical Genomics Board of Directors
  • Dec 11, 2017: Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system
  • Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests
  • Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results
  • Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes
  • Sep 26, 2017: Rx Savings Solutions Helps Quest Diagnostics' Health Plan Members Save Money On Prescription Drugs
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Quest Diagnostics Inc, Key Facts
  • Quest Diagnostics Inc, Key Employees
  • Quest Diagnostics Inc, Key Employee Biographies
  • Quest Diagnostics Inc, Major Products and Services
  • Quest Diagnostics Inc, History
  • Quest Diagnostics Inc, Subsidiaries
  • Quest Diagnostics Inc, Joint Venture
  • Quest Diagnostics Inc, Key Competitors
  • Quest Diagnostics Inc, Ratios based on current share price
  • Quest Diagnostics Inc, Annual Ratios
  • Quest Diagnostics Inc, Annual Ratios
  • Quest Diagnostics Inc, Annual Ratios
  • Quest Diagnostics Inc, Interim Ratios
  • Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Quest Diagnostics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Quest Diagnostics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Quest Diagnostics Inc, Performance Chart (2013 - 2017)
  • Quest Diagnostics Inc, Ratio Charts
  • Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Thermo Fisher Scientific Inc
  • Novant Health Inc
  • Life Technologies Corp
  • Laboratory Corp of America Holdings
  • Bio-Rad Laboratories Inc
  • Alere Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll